qfx 
Fans of classic 80s action shows, rejoice! The Tachyon Pulse podcast reports that Universal is considering including the iconic helicopter *Airwolf* in the new *Knight Rider* movie. While it might not be a major part, *Airwolf* could make a quick appearance or simply be mentioned in the film.
Fold has finally debuted its new Bitcoin rewards credit card, because apparently, we’re all secretly crypto billionaires in the making. 🤑 The card runs on the Visa network (fancy!) and is powered by Stripe Issuing (techy!). The best part? No more juggling categories, staking tiers, or deciphering complicated token systems. Just spend money, get Bitcoin. It’s like magic, but with spreadsheets. 📈
The FDA’s seal of approval for HeartFlow’s Plaque Analysis algorithm is no mere bureaucratic stamp. It is a signal to the world that this machine-learning tool, which renders 3D maps of arterial plaque, has crossed the threshold from promise to practicality. The company wasted no time declaring the product available for sale, its press release brimming with the confidence of a man who’s seen too many winters and knows the value of a warm fire.
The news was nothing new. Oh, sure, there was that long-standing afterglow from Nvidia’s announcement to sink a cool $5 billion into Intel’s pockets like a charity donation for the damned. Oh, and some new analyst ‘upgrades’-as if that means anything in this wretched hellscape we call finance. The S&P 500 plunged by 0.6% while Intel-oh blessed Intel-sailed triumphantly on its tiny wave of positivity.
Starring Jessie Buckley as the Bride and Christian Bale as Frankenstein, the new film will be released in theaters and IMAX on March 6, 2026.
A lot of fans expressed their disappointment online, saying the decision didn’t show proper respect for Cena’s final appearances.
Cardano (ADA), that most enigmatic of digital assets, currently trades at $0.82, a price point that suggests it has more in common with a teacup than a rocket ship. Despite a 24-hour volume of $1.8 billion, its weekly performance has been a masterclass in modesty-down 5%, one might say with the grace of a deflated balloon.
BPL-003, Atai’s antidepressant, is no mere molecule-it is a river carving through the bedrock of treatment-resistant depression. In an open-label phase 2a study, it coursed through patients like a thawing stream, dissolving the ice of despair with “rapid, clinically meaningful” effects. The collaboration with Beckley Psytech, a U.K.-based entity with the quiet precision of a watchmaker, suggests this is no fleeting ripple but a tide.
This updated version of the classic 1999 shoe takes the minimalist design even further than the Mostro Mule. It features only spiked rubber details around the sole. Available in black and khaki, the shoe has a breathable knit upper. Inspired by practical design, it’s a laceless slip-on created with para-athletes in mind, and a simple heel tab makes it easy for anyone to put on the extended sock-like shoe.
The proposal is now up for public scrutiny on X, where users are split between those who’d trade a kidney for cheaper transactions and those who fear their earnings will vanish like a mirage in the desert. The feedback stage is a critical juncture-will the proposal survive the gauntlet of opinions, or will it be buried under a mountain of skepticism?